The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance-Reference-Cited by-同舟云学术

The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance

Published:2018-04-20 Issue:10 Volume:20 Page:1321-1330
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Hersh David S¹,Harder Bryan G²,Roos Alison²,Peng Sen³,Heath Jonathan E⁴,Legesse Teklu⁴,Kim Anthony J¹⁵,Woodworth Graeme F¹⁵,Tran Nhan L²,Winkles Jeffrey A⁵⁶⁷^ORCID

Affiliation:

1. Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland

2. Departments of Cancer Biology and Neurosurgery, Mayo Clinic Arizona, Scottsdale, Arizona

3. Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona

4. Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland

5. University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

6. Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland

7. Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland

Funder

National Institutes of Health

American Cancer Society

Elsa U. Pardee Foundation

Ben and Catherine Ivy Foundation

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/20/10/1321/25741860/noy063.pdf

Reference50 articles.

1. Malignant gliomas in adults;Wen;N Engl J Med,2008

2. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014;Ostrom;Neuro Oncol,2017

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

5. Targeting adaptive glioblastoma: an overview of proliferation and invasion;Xie;Neuro Oncol,2014

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

2. KIF4A promotes epithelial–mesenchymal transition by activating the TGF-β/SMAD signaling pathway in glioma cells;Molecular and Cellular Biochemistry;2024-02-27

3. Endocytosis: the match point of nanoparticle-based cancer therapy;Journal of Materials Chemistry B;2024

4. Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells;ACS Nano;2023-10-09

5. Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma;Journal of Nanobiotechnology;2023-07-05